The increasing global burden of non-communicable diseases (NCDs), such as cardiovascular disorders, diabetes, and respiratory conditions, is a primary driver of the demand for hard capsules. Many long-term treatment regimens for these conditions rely on oral medications that are best delivered via capsule form to ensure sustained release or targeted absorption. The rising geriatric population,...